Vijay Yabannavar

Keine laufenden Positionen mehr

63 Jahre

Health Technology

Finance

Consumer Services

Ursprung des Netzwerks ersten Grades von Vijay Yabannavar

Einheit	Art der Einheit	Industrie
Emergent Product Development Seattle Emergent Product Development Seattle Pharmaceuticals: MajorHealth Technology Emergent Product Development Seattle discovers and develops biopharmaceutical products. It focuses on the discovery and development of novel medicines to treat inflammatory diseases and cancer. The company was founded by Peter A. Thompson, Jeffrey A. Ledbetter and Kendall M. Mohler in March 1999 and is headquartered in Seattle, WA. 5	Subsidiary	Pharmaceuticals: Major	5

Unternehmensgrafik - zweiten Grades

Beziehungen zu mehreren Unternehmen

Unternehmensverbindungen über das persönliche Netzwerk von Vijay Yabannavar

Unternehmen	Sektor	Verknüpfte Personen	Hauptposition
AMGEN INC.	Pharmaceuticals: Major	Daniel J. Burge	Chief Tech/Sci/R&D Officer
Immunex Corp. Immunex Corp. BiotechnologyHealth Technology Immunex Corporation is a leading biopharmaceutical company dedicated to improving lives through immune system science innovation	Biotechnology	Daniel J. Burge	Chief Tech/Sci/R&D Officer
CTI BIOPHARMA CORP.	Pharmaceuticals: Major	Scott Stromatt	Chief Tech/Sci/R&D Officer
Corixa Corp. Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT.	Biotechnology	Kathleen McKereghan Deeley	General Counsel
Thomas Jefferson University	College/University	Daniel J. Burge	Doctorate Degree
Ernst & Young LLP Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY.	Miscellaneous Commercial Services	John Bencich	Corporate Officer/Principal
University of Washington University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA.	College/University	Kathleen McKereghan Deeley Peter Thompson	Graduate Degree Corporate Officer/Principal
Gennao Bio, Inc. Gennao Bio, Inc. Pharmaceuticals: MajorHealth Technology Gennao Bio, Inc. is a privately-held genetic medicines company that is developing first-in-class, non-viral, targeted nucleic acid therapeutics utilizing its proprietary gene monoclonal antibody (gmab) platform technology. The company is based in Pennington, NJ. The company's gmab technology uses a novel, cell-penetrating antibody to non-covalently bind to, and deliver therapeutic levels of a wide variety of nucleic acid payloads, to select cells. Gennao Bio is initially focusing on addressing significant unmet needs in oncology and rare monogenic skeletal muscle diseases. The company's non-viral delivery platform offers significant advantages over traditional gene delivery systems as it can deliver multiple types of nucleic acids, allows for repeat dosing and dose optimization, and can be easily and affordably manufactured. The company was founded in 2020 by Bruce Turner, Elias Quijano, Peter M. Glazer, Stephen P. Squinto. Christopher M. Duke has been the CEO of the company since 2021.	Pharmaceuticals: Major	Peter Thompson	Director/Board Member
ALPINE IMMUNE SCIENCES, INC.	Biotechnology	Peter Thompson	Director/Board Member
OxOnc Development LP OxOnc Development LP BiotechnologyHealth Technology OxOnc Development LP operates as an oncology development company. It offers a drug development model that is based on the expertise and core competencies to design and execute clinical trials in oncology. The firm's business model is an integration of scientific, clinical, operational and financial resources, and provides a value-add proposition to its co-development partner by providing a profit and loss-sparing mechanism to fund research and development efforts externally. The company was founded in 2012 and is headquartered in George Town, Cayman Islands.	Biotechnology	Peter Thompson	Director/Board Member
SYNTHORX, INC.	Biotechnology	Peter Thompson	Director/Board Member
The Warren Alpert Medical School	College/University	Peter Thompson	Doctorate Degree
PREVAIL THERAPEUTICS INC.	Biotechnology	Peter Thompson	Director/Board Member
EDGEWISE THERAPEUTICS, INC.	Biotechnology	Peter Thompson	Founder
Angel Pharmaceuticals Co., Ltd. Angel Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Angel Pharmaceuticals Co., Ltd. operates as a biopharmaceutical company which develops medicines for treatment of cancer, autoimmune and infectious diseases. The company was founded by Richard Miller and Ted Wang on October 5, 2020 and is headquartered in Shanghai, China.	Biotechnology	Peter Thompson	Director/Board Member
DECIBEL THERAPEUTICS, INC.	Biotechnology	Peter Thompson	Director/Board Member
JANUX THERAPEUTICS, INC.	Biotechnology	Peter Thompson	Director/Board Member
ReCode Therapeutics, Inc. ReCode Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ReCode Therapeutics, Inc. operates as a biopharmaceutical company. It develops precision medicines for pulmonary diseases. The company is headquartered in Irvin, TX.	Pharmaceuticals: Major	Peter Thompson	Director/Board Member
ARS PHARMACEUTICALS, INC.	Pharmaceuticals: Major	Peter Thompson	Director/Board Member
Terremoto Biosciences, Inc. Terremoto Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Terremoto Biosciences, Inc. is a drug discovery and development company that creates highly targeted, small molecule medicines with unmatched selectivity, potency, and efficacy to deliver superior therapeutic benefit to patients. The company is based in San Francisco, CA. Terremoto is supported by leading investors, including OrbiMed, Third Rock Ventures, EcoR1 Capital, Novo Holdings, and Cormorant Capital. The company aims to expand the universe of drug targets and improve existing medicines by unleashing the power of covalent chemistry. Terremoto was founded by Peter A. Thompson and Matthew P. Jacobson, and Peter A. Thompson has been the CEO since incorporation.	Pharmaceuticals: Major	Peter Thompson	Founder
CORVUS PHARMACEUTICALS, INC.	Pharmaceuticals: Major	Peter Thompson	Founder
Taylor University	College/University	Daniel J. Burge	Undergraduate Degree
FORTE BIOSCIENCES, INC.	Biotechnology	Daniel J. Burge	Chief Tech/Sci/R&D Officer
DERMIRA, INC.	Pharmaceuticals: Major	Daniel J. Burge	Chief Tech/Sci/R&D Officer
University of San Diego	College/University	John Bencich	Undergraduate Degree
Seattle University	College/University	John Bencich	Masters Business Admin
Integrated Diagnostics, Inc. Integrated Diagnostics, Inc. Medical/Nursing ServicesHealth Services Integrated Diagnostics, Inc. operates as a molecular diagnostics firm. It develops diagnostics and measurement technologies that has a capability of measuring biomarkers for diagnosis and management of complex diseases. The company was founded by Jim Heath, David J. Galas, Leroy E. Hood, and Paul Edward Kearney and is headquartered Seattle, WA.	Medical/Nursing Services	John Bencich	Director of Finance/CFO
PMV PHARMACEUTICALS, INC.	Miscellaneous Commercial Services	Peter Thompson	Director/Board Member
ADAPTIMMUNE THERAPEUTICS PLC	Biotechnology	Peter Thompson	Director/Board Member
The University of Chicago	College/University	Scott Stromatt	Doctorate Degree
The University of Colorado	College/University	Scott Stromatt	Masters Business Admin
C.E. Unterberg, Towbin Holdings, Inc. C.E. Unterberg, Towbin Holdings, Inc. Investment ManagersFinance Part of Canaccord Genuity Group, Inc., C.E. Unterberg, Towbin Holdings, Inc. provides financial advisory services. The company is based in New York, NY.	Investment Managers	Scott Stromatt	Corporate Officer/Principal
NORTHWEST BIOTHERAPEUTICS, INC.	Pharmaceuticals: Major	Scott Stromatt	Chief Tech/Sci/R&D Officer
EMERGENT BIOSOLUTIONS INC.	Pharmaceuticals: Major	Scott Stromatt	Chief Tech/Sci/R&D Officer
APTEVO THERAPEUTICS INC.	Biotechnology	Scott Stromatt	Chief Tech/Sci/R&D Officer
California University of Pennsylvania	College/University	Kathleen McKereghan Deeley	Undergraduate Degree
University of California, Davis	College/University	Kathleen McKereghan Deeley	Undergraduate Degree